Effect of Baduanjin Sequential Therapy on the Quality of Life and Cardiac Function in Patients with AMI After PCI: A Randomized Controlled Trial

Table 1

Baseline clinical and procedural characteristics.

Variable	Control group (n = 39)	BST group (n = 43)	value
Clinical characteristics
Age (years)	61.49 ± 11.54	59.98 ± 10.86	0.543
Male, n (%)	30 (76.9)	29 (67.4)	0.34
Body mass index (kg/m^2)	24.62 ± 2.86	23.95 ± 2.35	0.25
Hypertension, n (%)	22 (56.4)	26 (60.5)	0.71
Dyslipidaemia, n (%)	11 (28.2)	14 (32.6)	0.669
History of smoker, n (%)	25 (64.1)	22 (51.2)	0.237
History of CAD, n (%)	1 (2.6)	6 (14)	0.148
Diabetes, n (%)	10 (25.6)	9 (20.9)	0.614
LVEF (%)	63.74 ± 8.52	61.07 ± 9.64	0.189
LVEDD (mm)	46.54 ± 3.73	44.83 ± 4.68	0.073
LVESD (mm)	29.77 ± 5.52	29.82 ± 5.71	0.97
NT-pro-BNP (pg/ml)	374 (108–1093)	408 (191–921)	0.66
WBC (10^9/L)	10.55 ± 3.12	10.97 ± 3.51	0.574
TG (mmol/L)	1.51 (1.09–2.19)	1.53 (1.10–2.30)	0.795
TC (mmol/L)	4.86 ± 0.85	4.87 ± 1.13	0.971
HDL-C (mmol/L)	1.10 ± 0.28	1.12 ± 0.44	0.856
LDL-C (mmol/L)	3.38 ± 0.78	3.53 ± 0.92	0.425
Drug treatment
Statins, n (%)	39 (100)	43 (100)
Aspirin, n (%)	39 (100)	43 (100)
Clopidogrel, n (%)	39 (100)	43 (100)
b-Blockers, n (%)	16 (41)	20 (46.5)	0.617
Calcium blockers, n (%)	6 (15.4)	5 (11.6)	0.618
ACE inhibitors, n (%)	6 (15.4)	3 (7)	0.388
ARBs, n (%)	6 (15.4)	14 (32.6)	0.71
Diuretics, n (%)	4 (10.3)	3 (7)	0.893
Procedural characteristics
Transradial access, n (%)	36 (92.3)	39 (90.7)	1
Target vessel
Left main	1 (2.6)	1 (2.6)	1
Left anterior descending	32 (82.1)	33 (76.7)	0.554
Left circumflex	20 (51.3)	19 (44.2)	0.521
Right coronary artery	23 (59)	25 (58.1)	0.939
Lesion location
Proximal	24 (61.5)	29 (67.4)	0.577
Middle	27 (69.2)	27 (62.8)	0.539
Distal	4 (10.3)	7 (16.3)	0.424
Branch	13 (33.3)	13 (30.2)	0.763
Preoperative TIMI 0	17 (43.6)	18 (41.9)	0.874
Preoperative TIMI 1	2 (5.1)	1 (2.3)	0.931
Preoperative TIMI 2	1 (2.6)	2 (4.7)	1
Preoperative TIMI 3	19 (48.7)	22 (51.2)	0.825
Postoperative TIMI 3	39 (100)	43 (100)
Lesion classification
Number of stents implanted	1.18 ± 0.389	1.09 ± 0.294	0.263

BMI, body mass index; CAD, coronary artery disease; NT-pro-BNP, N-terminal pro-brain natriuretic peptide; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ACE, angiotensin-converting enzyme; ARBs, angiotensin receptor blockers. The BMI is the weight in kilograms divided by the square of the height in meters. Values are expressed as the mean ± SD, the median with interquartile range, or n (%). values were calculated by t-test for continuous variables and by the chi-square test or Fisher’s exact test for categorical variables.